Загрузка...
Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments
SIMPLE SUMMARY: Myelodysplastic syndromes (MDS) are a group of diseases in which bone marrow stem cells acquire genetic alterations and can initiate leukemia, blocking the production of mature blood cells. It is of crucial importance to identify those genetic abnormalities because some of them can b...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7917605/ https://ncbi.nlm.nih.gov/pubmed/33668555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040784 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|